HIV molecular immunology database

 

Search Antibody Database

Found 2 matching records:

Displaying record number 233

Download this epitope record as JSON.

MAb ID 1D9D5 (1D9)
HXB2 Location Tat(2-21)
DNA(5834..5893)
Tat Epitope Map
Author Location Tat
Epitope EPVDPRLEWKHPGSQPKTA Epitope Alignment
EPVDPRLEWKHPGSQPKTA epitope logo
Ab Type N-term
Neutralizing  
Species (Isotype) mouse(IgG1)
Patient  
Immunogen vaccine
Keywords antibody interactions, binding affinity

Vaccine Details

Vaccine type protein
Vaccine component Tat

Notes

Showing 5 of 5 notes.

References

Showing 4 of 4 references.

Kanduc2008 Darja Kanduc, Rosario Serpico, Alberta Lucchese, and Yehuda Shoenfeld. Correlating Low-Similarity Peptide Sequences and HIV B-Cell Epitopes. Autoimmun. Rev., 7(4):291-296, Feb 2008. PubMed ID: 18295732. Show all entries for this paper.

Mhashilkar1995 A. M. Mhashilkar, J. Bagley, S. Y. Chen, A. M. Szilvay, D. G. Helland, and W. A. Marasco. Inhibition of HIV-1 Tat-Mediated LTR Transactivation and HIV-1 Infection by Anti-Tat Single Chain Intrabodies. EMBO J., 14:1542-1551, 1995. Anti-Tat intrabodies specific for the N-terminal activation domain of Tat, block Tat-mediated transactivation of the HIV-1 LTR and intracellular trafficking of Tat in mammalian cells. Thus single chain intrabodies can effectively target molecules in the cytoplasm and nuclear compartments of eukaryotic cells and anti-Tat intrabodies may be useful for gene therapy of HIV-1 infection and AIDS. PubMed ID: 7537216. Show all entries for this paper.

Theisen2006 Dietmar M. Theisen, Carola Pongratz, Katja Wiegmann, Francisco Rivero, Oleg Krut, and Martin Krönke. Targeting of HIV-1 Tat Traffic and Function by Transduction-Competent Single Chain Antibodies. Vaccine, 24(16):3127-3136, 12 Apr 2006. PubMed ID: 16497417. Show all entries for this paper.

Valvatne1996 H. Valvatne, A. M. Szilvay, and D. E. Helland. A Monoclonal Antibody Defines a Novel HIV Type 1 Tat Domain Involved in Trans-Cellular Trans-Activation. AIDS Res. Hum. Retroviruses, 12:611-619, 1996. CAT and beta-galactosidase assays, and immunofluorescence analysis were used to study the cellular uptake of the HIV-1 Tat protein. A MAb binding to the basic domain and the RGD sequence inhibits trans- activation by exogenous Tat. The inhibition of the cellular uptake of Tat by an anti-Tat monoclonal antibody and by the serum components implies specific binding of Tat to the cell membrane. PubMed ID: 8743086. Show all entries for this paper.


Displaying record number 240

Download this epitope record as JSON.

MAb ID 2D9D5
HXB2 Location Tat Tat Epitope Map
Author Location Tat
Epitope
Ab Type C-term
Neutralizing  
Species (Isotype) mouse(IgG)
Patient  
Immunogen vaccine
Keywords  

Vaccine Details

Vaccine type protein
Vaccine component Tat

Notes

Showing 1 of 1 note.

References

Showing 1 of 1 reference.

Mhashilkar1995 A. M. Mhashilkar, J. Bagley, S. Y. Chen, A. M. Szilvay, D. G. Helland, and W. A. Marasco. Inhibition of HIV-1 Tat-Mediated LTR Transactivation and HIV-1 Infection by Anti-Tat Single Chain Intrabodies. EMBO J., 14:1542-1551, 1995. Anti-Tat intrabodies specific for the N-terminal activation domain of Tat, block Tat-mediated transactivation of the HIV-1 LTR and intracellular trafficking of Tat in mammalian cells. Thus single chain intrabodies can effectively target molecules in the cytoplasm and nuclear compartments of eukaryotic cells and anti-Tat intrabodies may be useful for gene therapy of HIV-1 infection and AIDS. PubMed ID: 7537216. Show all entries for this paper.


Questions or comments? Contact us at immuno@lanl.gov
 
Managed by Triad National Security, LLC for the U.S. Department of Energy’s National Nuclear Security Administration
Copyright © 2022 Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health